APA (7th ed.) Citation

Y, E., AF, A., AY, S., NF, A. E., S, M., & NMFH, M. (2025). Therapeutic potential of spiramycin-nanoparticles and Aluvia in experimental congenital toxoplasmosis. Experimental parasitology, 279, 109069. https://doi.org/10.1016/j.exppara.2025.109069

Chicago Style (17th ed.) Citation

Y, Elsayed, Allam AF, Shehab AY, Abd El-Latif NF, Makled S, and Mogahed NMFH. "Therapeutic Potential of Spiramycin-nanoparticles and Aluvia in Experimental Congenital Toxoplasmosis." Experimental Parasitology 279 (2025): 109069. https://doi.org/10.1016/j.exppara.2025.109069.

MLA (9th ed.) Citation

Y, Elsayed, et al. "Therapeutic Potential of Spiramycin-nanoparticles and Aluvia in Experimental Congenital Toxoplasmosis." Experimental Parasitology, vol. 279, 2025, p. 109069, https://doi.org/10.1016/j.exppara.2025.109069.